Literature DB >> 30914325

Functional analysis of SOX10 mutations identified in Chinese patients with Kallmann syndrome.

Wenting Dai1, Jiayu Wu1, Yaguang Zhao1, Fang Jiang1, Ruizhi Zheng2, Dan-Na Chen3, Meichao Men4, Jia-Da Li5.   

Abstract

Kallmann syndrome (KS) is characterized by the association of anosmia and hypogonadotropic hypogonadism. The hypogonadotropic hypogonadism is due to deficient production, secretion or action of gonadotropin-releasing hormone (GnRH). Mutations in transcription factor SOX10 have been recently identified in patients with KS and hearing loss. In this study, we identified three novel SOX10 mutations in a cohort of Chinese KS patients by using exome sequencing. Two mutations (A44G and L80V) are in heterozygous state whereas the other one (G41V) is a homozygous mutation. The patient with a homozygous G41V mutation had impaired hearing in both ears, whereas the patient with a heterozygous L80V mutation showed subtle hearing impairment in the left ear. Functional studies indicated that all three SOX10 mutations showed reduced capacity to transactivate the MITF promoter alone or in synergy with PAX3, although they showed similar subcellular localization, and DNA binding ability. Our study further highlighted the significance of SOX10 haploinsufficiency as a genetic cause of KS with hearing problem.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Kallmann syndrome; SOX10; Transactivity

Mesh:

Substances:

Year:  2019        PMID: 30914325     DOI: 10.1016/j.gene.2019.03.039

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

Review 1.  Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease.

Authors:  Richard Quinton; Marco Bonomi; Biagio Cangiano; Du Soon Swee
Journal:  Hum Genet       Date:  2020-03-21       Impact factor: 4.132

2.  Targeted Next-Generation Sequencing Identifies Separate Causes of Hearing Loss in One Deaf Family and Variable Clinical Manifestations for the p.R161C Mutation in SOX10.

Authors:  Xiaoyu Yu; Yun Lin; Hao Wu
Journal:  Neural Plast       Date:  2020-08-28       Impact factor: 3.599

3.  Two novel mutations of PAX3 and SOX10 were characterized as genetic causes of Waardenburg Syndrome.

Authors:  Yongbo Yu; Wei Liu; Min Chen; Yang Yang; Yeran Yang; Enyu Hong; Jie Lu; Jun Zheng; Xin Ni; Yongli Guo; Jie Zhang
Journal:  Mol Genet Genomic Med       Date:  2020-03-13       Impact factor: 2.183

Review 4.  Kallmann Syndrome Due to Heterozygous Mutation in SOX10 Coexisting With Waardenburg Syndrome Type II: Case Report and Review of Literature.

Authors:  Kan Chen; Haoyu Wang; Yaxin Lai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-01       Impact factor: 5.555

5.  A novel SOX10 nonsense mutation in a patient with Kallmann syndrome and Waardenburg syndrome.

Authors:  Tetsuji Wakabayashi; Akihito Takei; Nobukazu Okada; Miki Shinohara; Manabu Takahashi; Shuichi Nagashima; Kenta Okada; Ken Ebihara; Shun Ishibashi
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-04-01

Review 6.  SOX10: 20 years of phenotypic plurality and current understanding of its developmental function.

Authors:  Veronique Pingault; Lisa Zerad; William Bertani-Torres; Nadege Bondurand
Journal:  J Med Genet       Date:  2021-10-19       Impact factor: 6.318

7.  Analysis of PLXNA1, NRP1, and NRP2 variants in a cohort of patients with isolated hypogonadotropic hypogonadism.

Authors:  Meichao Men; Dan-Na Chen; Jia-Da Li; Xinying Wang; Wang Zeng; Fang Jiang; Ruizhi Zheng; Wenting Dai
Journal:  Mol Genet Genomic Med       Date:  2021-10-11       Impact factor: 2.183

8.  SOX10 Mutation Screening for 117 Patients with Kallmann Syndrome.

Authors:  Hirohito Shima; Etsuro Tokuhiro; Shingo Okamoto; Mariko Nagamori; Tsutomu Ogata; Satoshi Narumi; Akie Nakamura; Yoko Izumi; Tomoko Jinno; Erina Suzuki; Maki Fukami
Journal:  J Endocr Soc       Date:  2021-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.